Please login to the form below

Not currently logged in
Email:
Password:

Emerging Companies

This page shows the latest Emerging Companies news and features for those working in and with pharma, biotech and healthcare.

Resilience acquires bluebird bio’s manufacturing facility as part of cell therapy alliance

Resilience acquires bluebird bio’s manufacturing facility as part of cell therapy alliance

The two companies plan to collaborate on the ‘next phase’ of bluebird bio's spin-off oncology cell therapy company 2seventy’s pipeline. ... The two companies are also planning to collaborate on the ‘next phase’ of 2seventy’s pipeline, and

Latest news

More from news
Approximately 0 fully matching, plus 56 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 14 partially matching documents found.

Latest appointments

  • Christie Anbar appointed global healthcare lead at Ruder Finn Christie Anbar appointed global healthcare lead at Ruder Finn

    In her new role, Anbar will lead the company’s partnership with clients ranging from major biopharmaceutical companies to emerging biotech, tech and health data pioneers, as well as patient advocacy ... In those roles, she led award-winning work for a

  • New hires at Abbott, Kite and Arrakis Therapeutics New hires at Abbott, Kite and Arrakis Therapeutics

    chairman of its Board of Directors. She has nearly 30 years of experience in the biotech industry as a leader of emerging companies. ... Katrine’s experience building dynamic, science-driven companies will serve as a critical resource for Arrakis as we

  • Orchard Therapeutics appoints Mark Rothera as CEO Orchard Therapeutics appoints Mark Rothera as CEO

    pipeline. Rothera brings 28 years’ experience in the biopharmaceutical industry including driving the transition of multiple emerging biotechnology companies from R&D stage to commercialisation, bringing rare disease therapies to the

  • Former Roche CEO and chairman joins Arix Bioscience Former Roche CEO and chairman joins Arix Bioscience

    His experience and judgement will be a tremendous asset to Arix Bioscience as we continue to support emerging and innovative companies globally.

  • Bayer veteran joins Aurinia as CEO Bayer veteran joins Aurinia as CEO

    Aurinia's chair Dr Richard Glickman said: “Stephen is a seasoned leader with a strong track record of delivering strategic direction and operational excellence to both established and emerging life sciences ... companies. “He is exceptionally

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Founded in 201, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...